Loading…
Singlet Oxygen Inhibits Agonist-Induced P-Selectin Expression and Formation of Platelet Aggregates
Major mediators of activated polymorphonuclear leukocytes (PMN) are the oxidants HOCl and chloramine, which are a source for the nonradical photon-emitting oxidant singlet oxygen (1O2). We were interested in a possible platelet-modulating activity of 1O2, As a stable 1O2 source we chose the mild oxi...
Saved in:
Published in: | Clinical and applied thrombosis/hemostasis 2001-07, Vol.7 (3), p.219-224 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Request full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c367t-3a7b8f06bb7198ab9660218630bf68444929464a1337c4f0fb834823530399d3 |
---|---|
cites | cdi_FETCH-LOGICAL-c367t-3a7b8f06bb7198ab9660218630bf68444929464a1337c4f0fb834823530399d3 |
container_end_page | 224 |
container_issue | 3 |
container_start_page | 219 |
container_title | Clinical and applied thrombosis/hemostasis |
container_volume | 7 |
creator | Stief, T.W. Jeske, W.P. Walenga, J. Schultz, C. Kretschmer, V. Fareed, J. |
description | Major mediators of activated polymorphonuclear leukocytes (PMN) are the oxidants HOCl and chloramine, which are a source for the nonradical photon-emitting oxidant singlet oxygen (1O2). We were interested in a possible platelet-modulating activity of 1O2, As a stable 1O2 source we chose the mild oxidant chloramine T® (CT), which mimics the natural chloramine N-chloro-taurine. Freshly drawn native whole blood from donors (n = 5) was incubated at 0 to 3 mM CT for I minute at 37°C. Then saline, 10 μM adenosine diphosphate (ADP), 5 μg/mL collagen, or 6.25 μM thrombin receptor activator peptide (TRAP) were added and the mixtures were allowed to incubate for 3 minutes at 37°C. Aliquots of activated blood were fixed in 1% para-formaldehyde. After removal of the fixative, platelets were labeled with anti-CD61-FITC and anti-CD62P-PE antibodies and analyzed by flow cytometry. An oxidant concentration-dependent decrease in the expression of -selectin appeared (at 3 mM CT to 39, 23, and 20% of the 100% saline control level for ADP, collagen, and TRAP, respectively). There was also an oxidant concentration-dependent decrease in the formation of platelet aggregates (at 3 mM CT to 8, 12, and 13% of the 100% saline control level for ADP, collagen, and TRAP, respectively; the 50% effective dose was 1.0 to 1.5 mM chloramine). In ADP- and TRAP-stimulated platelets, an oxidant-mediated increase in platelet fragments appeared (at 3 mM CT: three- to fourfold of the initial value). The addition to the blood of 30 mM of the oxy-radical scavenger mannitol in contrast to excess methionine did not antagonize these oxidative modulations of platelet activation. The results were confirmed using equimolar concentrations of NaOCl and N-chloro-taurine. This study shows that 1O2 inhibits platelets, decreasing the expression of CD62P and the formation of platelet aggregates. Activated PMN might modulate hemostasis, shifting it into an antithrombotic state. The physiologic signal action and the direct anticoagulant action of 1O2 (released by chloramines such as vancomycin) might be a new principle for pharmacologic intervention in atherothrombosis. |
doi_str_mv | 10.1177/107602960100700307 |
format | article |
fullrecord | <record><control><sourceid>proquest_AFRWT</sourceid><recordid>TN_cdi_proquest_journals_2344204662</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_107602960100700307</sage_id><sourcerecordid>2344204662</sourcerecordid><originalsourceid>FETCH-LOGICAL-c367t-3a7b8f06bb7198ab9660218630bf68444929464a1337c4f0fb834823530399d3</originalsourceid><addsrcrecordid>eNp9kE9rAjEQxUNpqa3tF-ihLPS8dfKnyeYooq0gKOh9SXaz25U1a5MI-u2bRcFDoaeZgd97M_MQesHwjrEQIwyCA5EcMIAAoCBu0AOWNEuJIPQ29hFIe2KAHr3fAmDJJb9HA4wZwzKjD0ivG1u3JiTL46k2Npnb70Y3wSfjurOND-nclofClMkqXZvWFKGxyfS4d8b7prOJsmUy69xOhX7qqmTVqmB6v3FdO1PHwT-hu0q13jxf6hBtZtPN5CtdLD_nk_EiLSgXIaVK6KwCrrWIpykteXwOZ5yCrnjGGJNEMs4UplQUrIJKZ5RlhH5QoFKWdIjezrZ71_0cjA_5tjs4GzfmhDJGgHFOIkXOVOE6752p8r1rdsqdcgx5n2r-N9Uoer1YH_TOlFfJJcYIjM6AV7W57v3H8hcwT32G</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2344204662</pqid></control><display><type>article</type><title>Singlet Oxygen Inhibits Agonist-Induced P-Selectin Expression and Formation of Platelet Aggregates</title><source>Sage Journals GOLD Open Access 2024</source><creator>Stief, T.W. ; Jeske, W.P. ; Walenga, J. ; Schultz, C. ; Kretschmer, V. ; Fareed, J.</creator><creatorcontrib>Stief, T.W. ; Jeske, W.P. ; Walenga, J. ; Schultz, C. ; Kretschmer, V. ; Fareed, J.</creatorcontrib><description>Major mediators of activated polymorphonuclear leukocytes (PMN) are the oxidants HOCl and chloramine, which are a source for the nonradical photon-emitting oxidant singlet oxygen (1O2). We were interested in a possible platelet-modulating activity of 1O2, As a stable 1O2 source we chose the mild oxidant chloramine T® (CT), which mimics the natural chloramine N-chloro-taurine. Freshly drawn native whole blood from donors (n = 5) was incubated at 0 to 3 mM CT for I minute at 37°C. Then saline, 10 μM adenosine diphosphate (ADP), 5 μg/mL collagen, or 6.25 μM thrombin receptor activator peptide (TRAP) were added and the mixtures were allowed to incubate for 3 minutes at 37°C. Aliquots of activated blood were fixed in 1% para-formaldehyde. After removal of the fixative, platelets were labeled with anti-CD61-FITC and anti-CD62P-PE antibodies and analyzed by flow cytometry. An oxidant concentration-dependent decrease in the expression of -selectin appeared (at 3 mM CT to 39, 23, and 20% of the 100% saline control level for ADP, collagen, and TRAP, respectively). There was also an oxidant concentration-dependent decrease in the formation of platelet aggregates (at 3 mM CT to 8, 12, and 13% of the 100% saline control level for ADP, collagen, and TRAP, respectively; the 50% effective dose was 1.0 to 1.5 mM chloramine). In ADP- and TRAP-stimulated platelets, an oxidant-mediated increase in platelet fragments appeared (at 3 mM CT: three- to fourfold of the initial value). The addition to the blood of 30 mM of the oxy-radical scavenger mannitol in contrast to excess methionine did not antagonize these oxidative modulations of platelet activation. The results were confirmed using equimolar concentrations of NaOCl and N-chloro-taurine. This study shows that 1O2 inhibits platelets, decreasing the expression of CD62P and the formation of platelet aggregates. Activated PMN might modulate hemostasis, shifting it into an antithrombotic state. The physiologic signal action and the direct anticoagulant action of 1O2 (released by chloramines such as vancomycin) might be a new principle for pharmacologic intervention in atherothrombosis.</description><identifier>ISSN: 1076-0296</identifier><identifier>EISSN: 1938-2723</identifier><identifier>DOI: 10.1177/107602960100700307</identifier><identifier>PMID: 11441983</identifier><language>eng</language><publisher>Thousand Oaks, CA: SAGE Publications</publisher><subject>Adenosine diphosphate ; Adenosine Diphosphate - pharmacology ; Animals ; Blood platelets ; Blood Platelets - drug effects ; Blood Platelets - metabolism ; Chloramines - pharmacology ; Collagen ; Collagen - pharmacology ; Depression, Chemical ; Free Radical Scavengers - pharmacology ; Gene Expression Regulation - drug effects ; Hemostasis - drug effects ; Hemostasis - physiology ; Humans ; Macaca mulatta ; Mannitol - pharmacology ; Methionine - pharmacology ; Neutrophils - physiology ; Oxidants - pharmacology ; Oxidation-Reduction ; P-Selectin - biosynthesis ; P-Selectin - genetics ; Platelet Aggregation - drug effects ; Platelet Aggregation Inhibitors - pharmacology ; Proteins - pharmacology ; Receptors, Thrombin ; Respiratory Burst ; Singlet Oxygen - pharmacology ; Taurine - analogs & derivatives ; Taurine - physiology ; Tosyl Compounds - pharmacology</subject><ispartof>Clinical and applied thrombosis/hemostasis, 2001-07, Vol.7 (3), p.219-224</ispartof><rights>Copyright SAGE PUBLICATIONS, INC. Jul 2001</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c367t-3a7b8f06bb7198ab9660218630bf68444929464a1337c4f0fb834823530399d3</citedby><cites>FETCH-LOGICAL-c367t-3a7b8f06bb7198ab9660218630bf68444929464a1337c4f0fb834823530399d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/107602960100700307$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2344204662?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,21965,25752,27852,27923,27924,37011,44589,44944,45332</link.rule.ids><linktorsrc>$$Uhttps://journals.sagepub.com/doi/full/10.1177/107602960100700307?utm_source=summon&utm_medium=discovery-provider$$EView_record_in_SAGE_Publications$$FView_record_in_$$GSAGE_Publications</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11441983$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stief, T.W.</creatorcontrib><creatorcontrib>Jeske, W.P.</creatorcontrib><creatorcontrib>Walenga, J.</creatorcontrib><creatorcontrib>Schultz, C.</creatorcontrib><creatorcontrib>Kretschmer, V.</creatorcontrib><creatorcontrib>Fareed, J.</creatorcontrib><title>Singlet Oxygen Inhibits Agonist-Induced P-Selectin Expression and Formation of Platelet Aggregates</title><title>Clinical and applied thrombosis/hemostasis</title><addtitle>Clin Appl Thromb Hemost</addtitle><description>Major mediators of activated polymorphonuclear leukocytes (PMN) are the oxidants HOCl and chloramine, which are a source for the nonradical photon-emitting oxidant singlet oxygen (1O2). We were interested in a possible platelet-modulating activity of 1O2, As a stable 1O2 source we chose the mild oxidant chloramine T® (CT), which mimics the natural chloramine N-chloro-taurine. Freshly drawn native whole blood from donors (n = 5) was incubated at 0 to 3 mM CT for I minute at 37°C. Then saline, 10 μM adenosine diphosphate (ADP), 5 μg/mL collagen, or 6.25 μM thrombin receptor activator peptide (TRAP) were added and the mixtures were allowed to incubate for 3 minutes at 37°C. Aliquots of activated blood were fixed in 1% para-formaldehyde. After removal of the fixative, platelets were labeled with anti-CD61-FITC and anti-CD62P-PE antibodies and analyzed by flow cytometry. An oxidant concentration-dependent decrease in the expression of -selectin appeared (at 3 mM CT to 39, 23, and 20% of the 100% saline control level for ADP, collagen, and TRAP, respectively). There was also an oxidant concentration-dependent decrease in the formation of platelet aggregates (at 3 mM CT to 8, 12, and 13% of the 100% saline control level for ADP, collagen, and TRAP, respectively; the 50% effective dose was 1.0 to 1.5 mM chloramine). In ADP- and TRAP-stimulated platelets, an oxidant-mediated increase in platelet fragments appeared (at 3 mM CT: three- to fourfold of the initial value). The addition to the blood of 30 mM of the oxy-radical scavenger mannitol in contrast to excess methionine did not antagonize these oxidative modulations of platelet activation. The results were confirmed using equimolar concentrations of NaOCl and N-chloro-taurine. This study shows that 1O2 inhibits platelets, decreasing the expression of CD62P and the formation of platelet aggregates. Activated PMN might modulate hemostasis, shifting it into an antithrombotic state. The physiologic signal action and the direct anticoagulant action of 1O2 (released by chloramines such as vancomycin) might be a new principle for pharmacologic intervention in atherothrombosis.</description><subject>Adenosine diphosphate</subject><subject>Adenosine Diphosphate - pharmacology</subject><subject>Animals</subject><subject>Blood platelets</subject><subject>Blood Platelets - drug effects</subject><subject>Blood Platelets - metabolism</subject><subject>Chloramines - pharmacology</subject><subject>Collagen</subject><subject>Collagen - pharmacology</subject><subject>Depression, Chemical</subject><subject>Free Radical Scavengers - pharmacology</subject><subject>Gene Expression Regulation - drug effects</subject><subject>Hemostasis - drug effects</subject><subject>Hemostasis - physiology</subject><subject>Humans</subject><subject>Macaca mulatta</subject><subject>Mannitol - pharmacology</subject><subject>Methionine - pharmacology</subject><subject>Neutrophils - physiology</subject><subject>Oxidants - pharmacology</subject><subject>Oxidation-Reduction</subject><subject>P-Selectin - biosynthesis</subject><subject>P-Selectin - genetics</subject><subject>Platelet Aggregation - drug effects</subject><subject>Platelet Aggregation Inhibitors - pharmacology</subject><subject>Proteins - pharmacology</subject><subject>Receptors, Thrombin</subject><subject>Respiratory Burst</subject><subject>Singlet Oxygen - pharmacology</subject><subject>Taurine - analogs & derivatives</subject><subject>Taurine - physiology</subject><subject>Tosyl Compounds - pharmacology</subject><issn>1076-0296</issn><issn>1938-2723</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNp9kE9rAjEQxUNpqa3tF-ihLPS8dfKnyeYooq0gKOh9SXaz25U1a5MI-u2bRcFDoaeZgd97M_MQesHwjrEQIwyCA5EcMIAAoCBu0AOWNEuJIPQ29hFIe2KAHr3fAmDJJb9HA4wZwzKjD0ivG1u3JiTL46k2Npnb70Y3wSfjurOND-nclofClMkqXZvWFKGxyfS4d8b7prOJsmUy69xOhX7qqmTVqmB6v3FdO1PHwT-hu0q13jxf6hBtZtPN5CtdLD_nk_EiLSgXIaVK6KwCrrWIpykteXwOZ5yCrnjGGJNEMs4UplQUrIJKZ5RlhH5QoFKWdIjezrZ71_0cjA_5tjs4GzfmhDJGgHFOIkXOVOE6752p8r1rdsqdcgx5n2r-N9Uoer1YH_TOlFfJJcYIjM6AV7W57v3H8hcwT32G</recordid><startdate>20010701</startdate><enddate>20010701</enddate><creator>Stief, T.W.</creator><creator>Jeske, W.P.</creator><creator>Walenga, J.</creator><creator>Schultz, C.</creator><creator>Kretschmer, V.</creator><creator>Fareed, J.</creator><general>SAGE Publications</general><general>SAGE PUBLICATIONS, INC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20010701</creationdate><title>Singlet Oxygen Inhibits Agonist-Induced P-Selectin Expression and Formation of Platelet Aggregates</title><author>Stief, T.W. ; Jeske, W.P. ; Walenga, J. ; Schultz, C. ; Kretschmer, V. ; Fareed, J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c367t-3a7b8f06bb7198ab9660218630bf68444929464a1337c4f0fb834823530399d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adenosine diphosphate</topic><topic>Adenosine Diphosphate - pharmacology</topic><topic>Animals</topic><topic>Blood platelets</topic><topic>Blood Platelets - drug effects</topic><topic>Blood Platelets - metabolism</topic><topic>Chloramines - pharmacology</topic><topic>Collagen</topic><topic>Collagen - pharmacology</topic><topic>Depression, Chemical</topic><topic>Free Radical Scavengers - pharmacology</topic><topic>Gene Expression Regulation - drug effects</topic><topic>Hemostasis - drug effects</topic><topic>Hemostasis - physiology</topic><topic>Humans</topic><topic>Macaca mulatta</topic><topic>Mannitol - pharmacology</topic><topic>Methionine - pharmacology</topic><topic>Neutrophils - physiology</topic><topic>Oxidants - pharmacology</topic><topic>Oxidation-Reduction</topic><topic>P-Selectin - biosynthesis</topic><topic>P-Selectin - genetics</topic><topic>Platelet Aggregation - drug effects</topic><topic>Platelet Aggregation Inhibitors - pharmacology</topic><topic>Proteins - pharmacology</topic><topic>Receptors, Thrombin</topic><topic>Respiratory Burst</topic><topic>Singlet Oxygen - pharmacology</topic><topic>Taurine - analogs & derivatives</topic><topic>Taurine - physiology</topic><topic>Tosyl Compounds - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stief, T.W.</creatorcontrib><creatorcontrib>Jeske, W.P.</creatorcontrib><creatorcontrib>Walenga, J.</creatorcontrib><creatorcontrib>Schultz, C.</creatorcontrib><creatorcontrib>Kretschmer, V.</creatorcontrib><creatorcontrib>Fareed, J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Clinical and applied thrombosis/hemostasis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Stief, T.W.</au><au>Jeske, W.P.</au><au>Walenga, J.</au><au>Schultz, C.</au><au>Kretschmer, V.</au><au>Fareed, J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Singlet Oxygen Inhibits Agonist-Induced P-Selectin Expression and Formation of Platelet Aggregates</atitle><jtitle>Clinical and applied thrombosis/hemostasis</jtitle><addtitle>Clin Appl Thromb Hemost</addtitle><date>2001-07-01</date><risdate>2001</risdate><volume>7</volume><issue>3</issue><spage>219</spage><epage>224</epage><pages>219-224</pages><issn>1076-0296</issn><eissn>1938-2723</eissn><abstract>Major mediators of activated polymorphonuclear leukocytes (PMN) are the oxidants HOCl and chloramine, which are a source for the nonradical photon-emitting oxidant singlet oxygen (1O2). We were interested in a possible platelet-modulating activity of 1O2, As a stable 1O2 source we chose the mild oxidant chloramine T® (CT), which mimics the natural chloramine N-chloro-taurine. Freshly drawn native whole blood from donors (n = 5) was incubated at 0 to 3 mM CT for I minute at 37°C. Then saline, 10 μM adenosine diphosphate (ADP), 5 μg/mL collagen, or 6.25 μM thrombin receptor activator peptide (TRAP) were added and the mixtures were allowed to incubate for 3 minutes at 37°C. Aliquots of activated blood were fixed in 1% para-formaldehyde. After removal of the fixative, platelets were labeled with anti-CD61-FITC and anti-CD62P-PE antibodies and analyzed by flow cytometry. An oxidant concentration-dependent decrease in the expression of -selectin appeared (at 3 mM CT to 39, 23, and 20% of the 100% saline control level for ADP, collagen, and TRAP, respectively). There was also an oxidant concentration-dependent decrease in the formation of platelet aggregates (at 3 mM CT to 8, 12, and 13% of the 100% saline control level for ADP, collagen, and TRAP, respectively; the 50% effective dose was 1.0 to 1.5 mM chloramine). In ADP- and TRAP-stimulated platelets, an oxidant-mediated increase in platelet fragments appeared (at 3 mM CT: three- to fourfold of the initial value). The addition to the blood of 30 mM of the oxy-radical scavenger mannitol in contrast to excess methionine did not antagonize these oxidative modulations of platelet activation. The results were confirmed using equimolar concentrations of NaOCl and N-chloro-taurine. This study shows that 1O2 inhibits platelets, decreasing the expression of CD62P and the formation of platelet aggregates. Activated PMN might modulate hemostasis, shifting it into an antithrombotic state. The physiologic signal action and the direct anticoagulant action of 1O2 (released by chloramines such as vancomycin) might be a new principle for pharmacologic intervention in atherothrombosis.</abstract><cop>Thousand Oaks, CA</cop><pub>SAGE Publications</pub><pmid>11441983</pmid><doi>10.1177/107602960100700307</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | ISSN: 1076-0296 |
ispartof | Clinical and applied thrombosis/hemostasis, 2001-07, Vol.7 (3), p.219-224 |
issn | 1076-0296 1938-2723 |
language | eng |
recordid | cdi_proquest_journals_2344204662 |
source | Sage Journals GOLD Open Access 2024 |
subjects | Adenosine diphosphate Adenosine Diphosphate - pharmacology Animals Blood platelets Blood Platelets - drug effects Blood Platelets - metabolism Chloramines - pharmacology Collagen Collagen - pharmacology Depression, Chemical Free Radical Scavengers - pharmacology Gene Expression Regulation - drug effects Hemostasis - drug effects Hemostasis - physiology Humans Macaca mulatta Mannitol - pharmacology Methionine - pharmacology Neutrophils - physiology Oxidants - pharmacology Oxidation-Reduction P-Selectin - biosynthesis P-Selectin - genetics Platelet Aggregation - drug effects Platelet Aggregation Inhibitors - pharmacology Proteins - pharmacology Receptors, Thrombin Respiratory Burst Singlet Oxygen - pharmacology Taurine - analogs & derivatives Taurine - physiology Tosyl Compounds - pharmacology |
title | Singlet Oxygen Inhibits Agonist-Induced P-Selectin Expression and Formation of Platelet Aggregates |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T06%3A40%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_AFRWT&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Singlet%20Oxygen%20Inhibits%20Agonist-Induced%20P-Selectin%20Expression%20and%20Formation%20of%20Platelet%20Aggregates&rft.jtitle=Clinical%20and%20applied%20thrombosis/hemostasis&rft.au=Stief,%20T.W.&rft.date=2001-07-01&rft.volume=7&rft.issue=3&rft.spage=219&rft.epage=224&rft.pages=219-224&rft.issn=1076-0296&rft.eissn=1938-2723&rft_id=info:doi/10.1177/107602960100700307&rft_dat=%3Cproquest_AFRWT%3E2344204662%3C/proquest_AFRWT%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c367t-3a7b8f06bb7198ab9660218630bf68444929464a1337c4f0fb834823530399d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2344204662&rft_id=info:pmid/11441983&rft_sage_id=10.1177_107602960100700307&rfr_iscdi=true |